Gergana O Drumeva

Ms. Gergana O Drumeva


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2026 in Cardio-Oncology
Verified
Journal Article
Open access
PDF file
GDGergana O Drumeva
Gergana O Drumeva
APAnne-Flore Plane
Anne-Flore Plane
DPDaniil R. Petrenyov
Daniil R. Petrenyov
PRPaula A. B. Ribeiro
Paula A. B. Ribeiro
CCCen Chen
Cen Chen
FTFrançois B. Tournoux
François B. Tournoux
Background: Ivabradine (IVAB) is an effective drug in patients with heart failure (HF). However, data in the context of chemotherapy-induced cardiomyopathy are limited. This study investigated the cardioprotective potential of IVAB in a doxorubicin (DOXO)-induced HF murine model, evaluating its effects on cardiac function, fibrosis, and its interaction with the renin-angiotensin system. Methods: C57BLC/6 female mice ( n = 36) completed the protocol and were allocated into 2 groups: control (CTRL, n = 4) and treatment by DOXO ( n = 32). DOXO administration (4 mg/kg/week, intraperitoneal) was performed over 5 weeks and followed by a 10-week gavage treatment with either water (H2O), IVAB (10 mg/kg/day), or metoprolol (METO, 100 mg/kg/day). Cardiac and kidney remodeling were assessed by echocardiography, pathology (with fibrosis assessed by picrosirius red (PSR) staining), and in vitro 125I-[Sar1,Ile8]Angiotensin II autoradiography for the measurement of AT1R levels. Results: After completion of DOXO injections, all mice demonstrated a lower cardiac function versus baseline ( p < 0.0001). During therapy administration, only IVAB reduced heart rate ( p < 0.0001) and improved cardiac function ( p < 0.05). One week after the end of therapy , 1) cardiac function in IVAB group declined to levels similar to the other groups; 2) there was no difference in cardiac mass between groups, but fibrosis was increased in all DOXO-groups vs. CTRL (H2O +47%, p = 0.055; IVAB +90%, p < 0.001 and METO +47% in kidneys, p = 0.058); and 3) renal AT1R level was reduced only in the H2O group versus CTRL (-421%, p < 0.01), while IVAB and METO groups maintained renal levels comparable to controls. Conclusions: IVAB transiently improved systolic function in this model, but this benefit was not sustained after treatment cessation and did not prevent late structural fibrosis remodeling. Both IVAB and METO prevented the reduction of renal AT1R expression observed in DOXO treated animals. Overall, these findings indicate that HR-lowering therapy with IVAB alone is insufficient to prevent fibrotic remodeling, highlighting the need for longer-term studies to evaluate its sustained efficacy and impact on structural remodeling, and to assess its translational potential in managing DIC in patients.

Verified
Journal Article
Open access
PDF file
GDGergana O Drumeva
Gergana O Drumeva
DPDaniil R. Petrenyov
Daniil R. Petrenyov
CCCen Chen
Cen Chen
SSShant Der Sarkissian
Shant Der Sarkissian
FTFrançois B. Tournoux
François B. Tournoux
JDJean N. DaSilva
Jean N. DaSilva
Myocardial infarction initiates complex remodeling processes involving the renin–angiotensin system, through activation of the angiotensin II type 1 receptor (AT1R). This study correlated AT1R expression with fibrosis and cardiac function in the heart and kidneys following cardiac ischemic injury in animal models. Male Sprague-Dawley rats underwent Sham surgery, Ischemia/Reperfusion (I/R, 20-min ligation) or Permanent Ligation (PL) of the left anterior descending artery. Cardiac function was assessed by echocardiography. AT1R expression was measured in the heart (infarct and remote areas) and kidneys (cortex, medulla) via [125Iodine]Sarcosine1-Isoleucine8-Angiotensin II autoradiography. Collagen deposition was evaluated through picrosirius red staining. Left ventricular (LV) ejection fraction declined in PL models but remained stable following I/R. Post-I/R, a transient increase in cardiac AT1R (day-3 to week-5) correlated with an increase in collagen, whereas after PL, elevations persisted through week-12. Infarct areas consistently displayed higher AT1R and collagen than remote areas. Renal AT1R and collagen levels were unchanged across groups. In analyses with pooled animals, cardiac AT1R expression correlated with collagen and inversely correlated with LV Fractional Shortening (LVFS), whereas LVFS inversely correlated with collagen deposition. These findings suggest that cardiac AT1R levels may serve as a target of cardiac remodeling, while changes in renal AT1R appear less pronounced.